Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ: RVPH · Real-Time Price · USD
1.240
+0.025 (2.06%)
At close: Nov 21, 2024, 4:00 PM
1.250
+0.010 (0.81%)
After-hours: Nov 21, 2024, 5:20 PM EST

RVPH Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
Net Income
-33.87-39.26-28.26-8.52-3.78-0.85
Upgrade
Depreciation & Amortization
----00
Upgrade
Stock-Based Compensation
1.473.410.180.15--
Upgrade
Other Operating Activities
-0.80.240.19-1.592.05-0.01
Upgrade
Change in Accounts Payable
3.50.333.01-0.50.780.16
Upgrade
Change in Other Net Operating Assets
-3.626.965.92-0.2-3.10.48
Upgrade
Operating Cash Flow
-33.32-28.32-18.96-10.67-4.07-0.22
Upgrade
Short-Term Debt Issued
-0.67--3.110.1
Upgrade
Total Debt Issued
0.420.67--3.110.1
Upgrade
Short-Term Debt Repaid
--0.67----
Upgrade
Total Debt Repaid
-0.55-0.67----
Upgrade
Net Debt Issued (Repaid)
-0.14---3.110.1
Upgrade
Issuance of Common Stock
34.0533.177.7931.69.72-
Upgrade
Financing Cash Flow
33.9133.177.7931.612.830.1
Upgrade
Net Cash Flow
0.594.85-11.1720.938.76-0.12
Upgrade
Free Cash Flow
-33.32-28.32-18.96-10.67-4.07-0.22
Upgrade
Free Cash Flow Per Share
-1.10-1.19-0.97-0.72-1.33-0.08
Upgrade
Cash Interest Paid
0.010.03--0.33-
Upgrade
Cash Income Tax Paid
---000
Upgrade
Levered Free Cash Flow
-17.67-13.99-8.54-6.87-4.151.3
Upgrade
Unlevered Free Cash Flow
-17.67-13.99-8.54-6.87-3.241.59
Upgrade
Change in Net Working Capital
-3.8-7.28-8.930.71.72-1.83
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.